Pantoprazole Cristers Pharma (Pantoprazole Sodium Sesquihydrate)

Pantoprazole is a proton pump inhibitor that reduces gastric acid production in several acid‑related disorders.

• Gastro‑esophageal reflux disease (GERD): helps heal erosive esophagitis and relieve heartburn symptoms.
• Erosive esophagitis: promotes healing of the damaged esophageal lining.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.

• Pantoprazole selectively inhibits the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid secretion, it markedly lowers both basal and stimulated gastric acidity, allowing mucosal healing and symptom relief in acid‑related conditions.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: kidney inflammation.
• Severe hypersensitivity: rash, angioedema, anaphylaxis.
• Low magnesium levels: may cause muscle cramps or arrhythmias.
• Fracture risk: long‑term use linked to bone density loss.
• Liver enzyme elevation: potential hepatotoxicity.

When prescribing Pantoprazole, clinicians should consider several safety aspects.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor magnesium levels: especially with prolonged therapy.
• Evaluate bone health: consider calcium/vitamin D supplementation for long‑term users.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at below 25°C: keep in the original container, protect from moisture and light.

Pantoprazole can affect the absorption and metabolism of several co‑administered drugs.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption.
• Atazanavir: markedly decreased antiviral exposure.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR.
• Digoxin: possible rise in serum levels.
• Methotrexate: reduced clearance at high doses.
• HIV protease inhibitors (e.g., ritonavir): altered plasma concentrations.